Immix Biopharma, Inc. IMMX
7.49 USD -0.35 (-4.46%)
As ofNov 16, 2026, 3:37 PM EST
7.49 Day range 8.01
3.78 52-week range 15.10
- YTD
- +43.21%
- 1 year
- +77.91%
Benzinga news
benzinga.com HC Wainwright & Co. Maintains Buy on Immix Biopharma, Raises Price Target to $27 HC Wainwright & Co. analyst Robert Burns maintains Immix Biopharma (NASDAQ:IMMX) with a Buy and raises the price target from $25 to $27.
benzinga.com Immix Biopharma Q3 EPS $(0.19), Inline Immix Biopharma (NASDAQ:IMMX) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a 20.83 percent increase over losses of $(0.24) per share from the same…
benzinga.com Immix Biopharma To Present An NXC-201 Abstract At American Society Of Hematology Annual Meeting, December 12-15 ASH Oral Presentation Details:Event 68th ASH Annual Meeting and Exposition, New Orleans, LATitle "45-patient safety and efficacy data for NXC-201 from Nexicart-2, the first U.S. trial of CAR-T in
